- Contractors
- Octapharma USA Inc.
Octapharma USA Inc.
Federal contractor · Biological Product (except Diagnostic) Manufacturing
Octapharma USA has 10 federal contracts of $100,000 or more active since October 2023, with $15.2M obligated, from 1 agency. None is running now.
- Contracts
- 10 since FY2024$15,220,000 obligated, contracts of $100,000 or more
- Running now
- None9 ended in the last 12 months
- Biggest customer
- Defense Health Agency$15.2M on 10 contracts
- Main industry
- Biological Product (except Diagnostic) ManufacturingNAICS 325414
- UEI
- FKJKNJVR1HV4Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2025 | $5,500,000 |
| FY2026 | $9,720,000 |
Running contracts
No contract of $100,000 or more is running now.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Defense Health Agency10 contracts | $15,220,000 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 · 10 contracts | $15,220,000 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| New Jersey5 contracts | $7,920,000 | |
| California2 contracts | $3,600,000 | |
| Maryland2 contracts | $3,600,000 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Defense Health Agency: see the list.
Get new notices like Octapharma USA's work
New contract opportunities under NAICS 325414, biological product (except diagnostic) manufacturing, the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy